NASDAQ:KIDS - Orthopediatrics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$38.32 -0.02 (-0.05 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$38.32
Today's Range$38.0108 - $39.23
52-Week Range$14.00 - $39.89
Volume30,379 shs
Average Volume53,662 shs
Market Capitalization$490.88 million
P/E Ratio-6.72
Dividend YieldN/A
Beta0.11
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.62 million
Book Value$3.74 per share

Profitability

Net Income$-8,930,000.00

Miscellaneous

Employees69
Market Cap$490.88 million
Next Earnings Date3/6/2019 (Estimated)
OptionableNot Optionable

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) posted its quarterly earnings data on Wednesday, October, 31st. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.03. The firm had revenue of $15.82 million for the quarter, compared to analysts' expectations of $15.19 million. Orthopediatrics had a negative return on equity of 65.26% and a negative net margin of 55.97%. Orthopediatrics's quarterly revenue was up 27.8% on a year-over-year basis. During the same quarter last year, the firm posted ($1.70) earnings per share. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Orthopediatrics.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics issued an update on its FY 2018 earnings guidance on Monday, January, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $57.5-57.7 million, compared to the consensus revenue estimate of $57.16 million.Orthopediatrics also updated its Q4 2018 guidance to EPS.

What price target have analysts set for KIDS?

4 analysts have issued 12-month target prices for Orthopediatrics' stock. Their forecasts range from $30.00 to $44.00. On average, they anticipate Orthopediatrics' share price to reach $37.00 in the next twelve months. This suggests that the stock has a possible downside of 3.4%. View Analyst Price Targets for Orthopediatrics.

What is the consensus analysts' recommendation for Orthopediatrics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

What are Wall Street analysts saying about Orthopediatrics stock?

Here are some recent quotes from research analysts about Orthopediatrics stock:
  • 1. BTIG Research analysts commented, "PT to $37 We are raising our KIDS PT to $37 (Street high) from $35 as we expect shares to move progressively higher over FY19. KIDS ended FY18 with the launch of 2 new products and a successful capital raise that saw needed liquidity added to the stock. We believe the incremental net proceeds, ~$43.7M, raised from the stock offering will allow KIDS to enter FY19 with ample capital to accelerate instrument investments and fund additional R&D to keep the product pipeline full. As KIDS adds to its instrument set levels, distributors are able to seek incremental new business and historically KIDS has seen a positive return of $1.20 to $1.50 for each dollar invested in instrumentation." (1/2/2019)
  • 2. According to Zacks Investment Research, "OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. " (1/2/2019)

Has Orthopediatrics been receiving favorable news coverage?

Headlines about KIDS stock have trended somewhat negative recently, according to InfoTrie. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthopediatrics earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the immediate future.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include Akorn (AKRX), AbbVie (ABBV), Freeport-McMoRan (FCX), Honeywell International (HON), Nike (NKE), Advanced Micro Devices (AMD), Cypress Semiconductor (CY), Intel (INTC), Nektar Therapeutics (NKTR) and PepsiCo (PEP).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.56%), Riverbridge Partners LLC (3.29%), RTW Investments LP (1.76%), Prospect Capital Advisors LLC (1.60%), Royce & Associates LP (1.51%) and Northern Trust Corp (1.05%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Harold Ruf and Kevin Unger. View Institutional Ownership Trends for Orthopediatrics.

Which institutional investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS and D. E. Shaw & Co. Inc.. Company insiders that have sold Orthopediatrics company stock in the last year include Daniel J Gerritzen, David R Bailey, Fred Hite and Kevin Unger. View Insider Buying and Selling for Orthopediatrics.

Which institutional investors are buying Orthopediatrics stock?

KIDS stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, RTW Investments LP, Prospect Capital Advisors LLC, BlackRock Inc., Bank of America Corp DE, Northern Trust Corp, Monashee Investment Management LLC and Geode Capital Management LLC. Company insiders that have bought Orthopediatrics stock in the last two years include David R Pelizzon and Harold Ruf. View Insider Buying and Selling for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $38.32.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $490.88 million and generates $45.62 million in revenue each year. The company earns $-8,930,000.00 in net income (profit) each year or ($5.70) on an earnings per share basis. Orthopediatrics employs 69 workers across the globe.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is http://www.orthopediatrics.com.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  159 (Vote Underperform)
Total Votes:  327
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel